New devices aim to take the sting out of insulin injections for children
NCT ID NCT07239700
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two simple devices—Buzzy, which uses cold and vibration, and TickleFlex, a soft pen attachment—to see if they can reduce pain and fear during insulin injections in children aged 6 to 12 with type 1 diabetes. 90 children will be randomly assigned to use one of the devices or receive a standard injection. Pain and fear levels will be reported by the child, parent, and researcher right after the shot.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hakkari University
Hakkari, Centre, 65030, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can type 1 diabetes hold kids back from being fit and active? a study aims to find out.
- Three telehealth sessions could ease the burden of type 1 diabetes on families
- Digital dashboard aims to transform diabetes care for kids
- Will a sticky patch stay put? study tests future pump design on kids
- Hidden heart risk in kids with diabetes: new study investigates
- Video Game-Style education could help kids control diabetes